Works by Shivane, Vyankatesh K.


Results: 6
    1

    Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial.

    Published in:
    Journal of Diabetes Investigation, 2018, v. 9, n. 3, p. 579, doi. 10.1111/jdi.12746
    By:
    • Ma, Ronald C. W.;
    • Del Prato, Stefano;
    • Gallwitz, Baptist;
    • Shivane, Vyankatesh K.;
    • Lewis‐d'agostino, Diane;
    • Bailes, Zelie;
    • Patel, Sanjay;
    • Lee, Jisoo;
    • Von Eynatten, Maximilian;
    • Di Domenico, Maximiliano;
    • Ross, Stuart A.
    Publication type:
    Article
    2
    3
    4
    5
    6

    A 52‐week extension study of switching from gemigliptin vs sitagliptin to gemigliptin only as add‐on therapy for patients with type 2 diabetes who are inadequately controlled with metformin alone.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1535, doi. 10.1111/dom.13256
    By:
    • for the Gemigliptin Study 006 Group;
    • Jung, Chan‐Hee;
    • Rhee, Eun‐Jung;
    • Lee, Won‐Young;
    • Min, Kyung Wan;
    • Shivane, Vyankatesh K.;
    • Sosale, Aravind R.;
    • Jang, Hak Chul;
    • Chung, Choon Hee;
    • Nam‐Goong, Il Seong
    Publication type:
    Article